» Articles » PMID: 28168445

Regulation of the H-ATP Synthase by IF1: a Role in Mitohormesis

Overview
Publisher Springer
Specialty Biology
Date 2017 Feb 8
PMID 28168445
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The mitochondrial H-ATP synthase is a primary hub of cellular homeostasis by providing the energy required to sustain cellular activity and regulating the production of signaling molecules that reprogram nuclear activity needed for adaption to changing cues. Herein, we summarize findings regarding the regulation of the activity of the H-ATP synthase by its physiological inhibitor, the ATPase inhibitory factor 1 (IF1) and their functional role in cellular homeostasis. First, we outline the structure and the main molecular mechanisms that regulate the activity of the enzyme. Next, we describe the molecular biology of IF1 and summarize the regulation of IF1 expression and activity as an inhibitor of the H-ATP synthase emphasizing the role of IF1 as a main driver of energy rewiring and cellular signaling in cancer. Findings in transgenic mice in vivo indicate that the overexpression of IF1 is sufficient to reprogram energy metabolism to an enhanced glycolysis and activate reactive oxygen species (ROS)-dependent signaling pathways that promote cell survival. These findings are placed in the context of mitohormesis, a program in which a mild mitochondrial stress triggers adaptive cytoprotective mechanisms that improve lifespan. In this regard, we emphasize the role played by the H-ATP synthase in modulating signaling pathways that activate the mitohormetic response, namely ATP, ROS and target of rapamycin (TOR). Overall, we aim to highlight the relevant role of the H-ATP synthase and of IF1 in cellular physiology and the need of additional studies to decipher their contributions to aging and age-related diseases.

Citing Articles

The homolog of ATPase inhibitory factor 1 is critical for mitochondrial cristae maintenance and stress response.

Usey M, Ruberto A, Parker K, Huet D Mol Biol Cell. 2024; 36(1):ar6.

PMID: 39602296 PMC: 11742118. DOI: 10.1091/mbc.E24-08-0344.


IF1 is a cold-regulated switch of ATP synthase hydrolytic activity to support thermogenesis in brown fat.

Brunetta H, Jung A, Valdivieso-Rivera F, de Campos Zani S, Guerra J, Furino V EMBO J. 2024; 43(21):4870-4891.

PMID: 39284909 PMC: 11535227. DOI: 10.1038/s44318-024-00215-0.


The homolog of ATPase inhibitory factor 1 is critical for mitochondrial cristae maintenance and stress response.

Usey M, Ruberto A, Huet D bioRxiv. 2024; .

PMID: 39149366 PMC: 11326266. DOI: 10.1101/2024.08.09.607411.


The current insights of mitochondrial hormesis in the occurrence and treatment of bone and cartilage degeneration.

Da W, Chen Q, Shen B Biol Res. 2024; 57(1):37.

PMID: 38824571 PMC: 11143644. DOI: 10.1186/s40659-024-00494-1.


Ablation of impairs metabolic reprogramming and proliferation of T lymphocytes and compromises mouse survival.

Romero-Carraminana I, Dominguez-Zorita S, Esparza-Molto P, Cuezva J iScience. 2024; 27(6):109863.

PMID: 38799559 PMC: 11126974. DOI: 10.1016/j.isci.2024.109863.


References
1.
Chae S, Ahn B, Byun K, Cho Y, Yu M, Lee B . A systems approach for decoding mitochondrial retrograde signaling pathways. Sci Signal. 2013; 6(264):rs4. DOI: 10.1126/scisignal.2003266. View

2.
Santacatterina F, Sanchez-Cenizo L, Formentini L, Mobasher M, Casas E, Rueda C . Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Oncotarget. 2015; 7(1):490-508. PMC: 4808013. DOI: 10.18632/oncotarget.6357. View

3.
Carraro M, Giorgio V, Sileikyte J, Sartori G, Forte M, Lippe G . Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem. 2014; 289(23):15980-5. PMC: 4047373. DOI: 10.1074/jbc.C114.559633. View

4.
Wittig I, Schagger H . Supramolecular organization of ATP synthase and respiratory chain in mitochondrial membranes. Biochim Biophys Acta. 2009; 1787(6):672-80. DOI: 10.1016/j.bbabio.2008.12.016. View

5.
Lopez-Rios F, Sanchez-Arago M, Garcia-Garcia E, Ortega A, Berrendero J, Pozo-Rodriguez F . Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res. 2007; 67(19):9013-7. DOI: 10.1158/0008-5472.CAN-07-1678. View